Biological actions and therapeutic potential of the glucagon-like peptides

胰高血糖素 化学 药理学 医学 计算生物学 生物化学 生物 激素
作者
Daniel J. Drucker
出处
期刊:Gastroenterology [Elsevier BV]
卷期号:122 (2): 531-544 被引量:508
标识
DOI:10.1053/gast.2002.31068
摘要

The glucagon-like peptides (GLP-1 and GLP-2) are proglucagon-derived peptides cosecreted from gut endocrine cells in response to nutrient ingestion. GLP-1 acts as an incretin to lower blood glucose via stimulation of insulin secretion from islet β cells. GLP-1 also exerts actions independent of insulin secretion, including inhibition of gastric emptying and acid secretion, reduction in food ingestion and glucagon secretion, and stimulation of β-cell proliferation. Administration of GLP-1 lowers blood glucose and reduces food intake in human subjects with type 2 diabetes. GLP-2 promotes nutrient absorption via expansion of the mucosal epithelium by stimulation of crypt cell proliferation and inhibition of apoptosis in the small intestine. GLP-2 also reduces epithelial permeability, and decreases meal-stimulated gastric acid secretion and gastrointestinal motility. Administration of GLP-2 in the setting of experimental intestinal injury is associated with reduced epithelial damage, decreased bacterial infection, and decreased mortality or gut injury in rodents with chemically induced enteritis, vascular-ischemia reperfusion injury, and dextran sulfate–induced colitis. GLP-2 also attenuates chemotherapy-induced mucositis via inhibition of drug-induced apoptosis in the small and large bowel. GLP-2 improves intestinal adaptation and nutrient absorption in rats after major small bowel resection, and in humans with short bowel syndrome. The actions of GLP-2 are mediated by a distinct GLP-2 receptor expressed on subsets of enteric nerves and enteroendocrine cells in the stomach and small and large intestine. The beneficial actions of GLP-1 and GLP-2 in preclinical and clinical studies of diabetes and intestinal disease, respectively, has fostered interest in the potential therapeutic use of these gut peptides. Nevertheless, the actions of the glucagon-like peptides are limited in duration by enzymatic inactivation via cleavage at the N-terminal penultimate alanine by dipeptidyl peptidase IV (DP IV). Hence, inhibitors of DP IV activity, or DP IV-resistant glucagon-like peptide analogues, may be alternative therapeutic approaches for treatment of human diseases.GASTROENTEROLOGY 2002;122:531-544

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
慕青的应助被符聪采纳,获得10
刚刚
刚刚
生动书竹发布了新的文献求助10
刚刚
超级送终完成签到,获得积分10
1秒前
李爱国的应助被ldroc采纳,获得10
1秒前
Jasper的应助被WYL采纳,获得10
1秒前
丘比特的应助被江sir采纳,获得10
1秒前
1秒前
xiuuu完成签到,获得积分10
2秒前
KYC完成签到,获得积分10
2秒前
不爱喝酒的应助被hana采纳,获得10
2秒前
。。。完成签到,获得积分10
3秒前
3秒前
搞怪冰岚发布了新的文献求助10
3秒前
3秒前
呼呼呼呼发布了新的文献求助10
4秒前
辉辉完成签到,获得积分10
4秒前
4秒前
英姑的应助被zhang采纳,获得10
5秒前
心碎的小蛋挞完成签到,获得积分10
5秒前
6秒前
嘻嘻哈哈的应助被CarryLJR采纳,获得10
6秒前
共享精神的应助被晴空采纳,获得10
6秒前
6秒前
昵称被注册完了完成签到,获得积分10
6秒前
7秒前
传奇3的应助被123采纳,获得10
7秒前
7秒前
7秒前
FashionBoy的应助被细心老姆采纳,获得10
7秒前
8秒前
宋亚轩发布了新的文献求助10
8秒前
prpr发布了新的文献求助10
9秒前
超级的猕猴桃完成签到,获得积分10
9秒前
9秒前
怕孤单的以寒完成签到 ,获得积分10
9秒前
9秒前
唐很甜完成签到,获得积分10
10秒前
李健的应助被menggu采纳,获得10
10秒前
何曼慈发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175853
求助须知:如何正确求助?哪些是违规求助? 9567457
关于积分的说明 21792632
捐赠科研通 7770447
什么是DOI,文献DOI怎么找? 3431918
关于科研通互助平台的介绍 2556276
邀请新用户注册赠送积分活动 2477418